Tuesday, April 22, 2025

Yearly Archives: 2020

Mallinckrodt Announces U.S. FDA Filing Acceptance of New Drug Application for Terlipressin for Treatment of Hepatorenal Syndrome Type 1 (HRS-1)

April 22, 2020: "Mallinckrodt plc, a global biopharmaceutical company announced that the U.S.FDA has accepted for review the company's New Drug Application (NDA) for terlipressin,...

Novartis Kymriah® receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma

April 22, 2020: "Novartis announced that the US Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Kymriah® (tisagenlecleucel), for an...

Confirmation of COVID-19 in Two Pet Cats in New York

April 22, 2020: "The U.S. Centers for Disease Control and Prevention (CDC) and the United States Department of Agriculture’s (USDA) National Veterinary Services...

Hard fought gains in immunization coverage at risk without critical health services, warns WHO

April 23, 2020: "Shutting down immunization services in the COVID-19 pandemic risks triggering a resurgence of diseases that can be prevented with safe...

Novartis announces new Mayzent® (siponimod) data show sustained effect in delaying disability for up to five years in patients with secondary progressive multiple sclerosis...

April 21, 2020: "Novartis announced new Mayzent® (siponimod) data in the April supplemental issue of Neurology®, the medical journal of the American Academy of Neurology. The data...

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

April 21, 2020:" Bayer announced its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) is launching a...

Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection

April 21, 2020: 'The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued...

Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19

Chloroquine or Hydroxychloroquine Recommendation: There are insufficient clinical data to recommend either for or against using chloroquine or hydroxychloroquine for the treatment of COVID-19 (AIII). When chloroquine or hydroxychloroquine is used, clinicians should monitor the patient for...

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients

April 20, 2020:  "Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial...

UN agencies issue urgent call to fund the global emergency supply system to fight COVID-19

April 20, 2020: "The heads of the United Nations’ major agencies have issued a warning of the risk of COVID-19 to the world’s most vulnerable...

New study to explore the effects of social distancing launched online

April 21, 2020: Researchers at the University of Oxford are looking for volunteers from across the globe to take part in a new study looking into...

Five Oxford COVID-19 projects receive UKRI funding

April 20,2020: "Five projects from across Oxford University's Medical Sciences Division are amongst twenty-one new studies into the novel coronavirus which have been funded...
- Advertisment -

Most Read